← Back to Search

High-Intensity Interval Nordic Walking for Coronary Artery Disease (HIIT-NoW Trial)

N/A
Recruiting
Led By Jennifer L Reed, PhD
Research Sponsored by Ottawa Heart Institute Research Corporation
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Willing to come onsite for exercise sessions
Patients with coronary artery disease treated with PCI or CABG
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to week 11 follow up
Awards & highlights

HIIT-NoW Trial Summary

This trial will test if a new exercise program that combines high-intensity interval training and Nordic walking can improve physical and mental health in patients with coronary artery disease.

Who is the study for?
This trial is for patients at least 40 years old with coronary artery disease who have had a stent inserted or heart bypass surgery. They must be willing to attend exercise sessions on-site, able to perform an exercise test measuring heart and lung function, and not currently in cardiac rehab.Check my eligibility
What is being tested?
The study is testing if high-intensity interval Nordic walking can improve physical and mental health better than standard cardiovascular rehabilitation. It's a new way of exercising that works the whole body by using special poles while walking.See study design
What are the potential side effects?
While specific side effects are not listed, high-intensity exercises may lead to muscle soreness, fatigue, increased heart rate during activity, and potential strain on the cardiovascular system especially in those with pre-existing conditions.

HIIT-NoW Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am willing to attend exercise sessions in person.
Select...
I have had heart artery treatment with stenting or bypass surgery.
Select...
I am 40 years old or older.

HIIT-NoW Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to week 11 follow up
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to week 11 follow up for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Adherence
Adverse events
Compliance
+3 more
Secondary outcome measures
Blood pressure
Cardiorespiratory fitness
Depression
+9 more

HIIT-NoW Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: High-intensity interval Nordic walkingExperimental Treatment1 Intervention
Participants will receive high-intensity interval Nordic walking training.
Group II: ControlActive Control1 Intervention
Participants will undergo standard cardiovascular rehabilitation.

Find a Location

Who is running the clinical trial?

Ottawa Heart Institute Research CorporationLead Sponsor
188 Previous Clinical Trials
92,534 Total Patients Enrolled
49 Trials studying Coronary Artery Disease
37,856 Patients Enrolled for Coronary Artery Disease
Jennifer L Reed, PhDPrincipal InvestigatorOttawa Heart Institute Research Corporation
6 Previous Clinical Trials
609 Total Patients Enrolled
1 Trials studying Coronary Artery Disease
135 Patients Enrolled for Coronary Artery Disease

Media Library

High-intensity interval Nordic walking Clinical Trial Eligibility Overview. Trial Name: NCT05434117 — N/A
Coronary Artery Disease Research Study Groups: High-intensity interval Nordic walking, Control
Coronary Artery Disease Clinical Trial 2023: High-intensity interval Nordic walking Highlights & Side Effects. Trial Name: NCT05434117 — N/A
High-intensity interval Nordic walking 2023 Treatment Timeline for Medical Study. Trial Name: NCT05434117 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Could you explain what the principal aims of this trial are?

"This clinical trial is primarily evaluating participants' subjective experience with exercise over an 11-week period. Secondary metrics of interest include functional capacity assessed through a 6-minute walk test, cardiorespiratory fitness measured by symptom-limited CPET exams, and depression levels determined using the Beck Depression Inventory-II (higher scores representing more severe symptoms)."

Answered by AI

Are current recruitment efforts underway for this medical experiment?

"Clinicaltrials.gov states that this medical trial has ceased recruitment, as its last update was on September 9th 2022. Despite being inactive at the moment, there are still 573 other trials actively seeking participants for their studies."

Answered by AI
~17 spots leftby Apr 2025